Buhl, A;Page, S;Heegaard, NH;von Landenberg, P;Luppa, PBOptical biosensor-based characterization of anti-double-stranded DNA monoclonal antibodies as possible new standards for laboratory tests.Biosens Bioelectron2009251198-203
Metzger, J;Luppa, PB;Good, DM;Mischak, HAdapting mass spectrometry-based platforms for clinical proteomics applications: The capillary electrophoresis coupled mass spectrometry paradigm.Crit Rev Clin Lab Sci2009463129-52
Novotny, AR;Luppa, P;Rosenberg, R;Schneider, H;Maak, M;Bartels, H;Holzmann, B;Friess, HProcalcitonin can be used for monitoring sepsis in patients with medullary thyroid carcinoma.Thyroid200919111287-9
Spiessberger, B;Bernhard, D;Herrmann, S;Feil, S;Werner, C;Luppa, PB;Hofmann, FcGMP-dependent protein kinase II and aldosterone secretion.FEBS J200927641007-13
Mooney, MH;Bergwerff, AA;van Meeuwen, JA;Luppa, PB;Elliott, CTBiosensor-based detection of reduced sex hormone-binding globulin binding capacities in response to growth-promoter administrations.Anal Chim Acta20096371-2235-40
Laika, B;Leucht, S;Heres, S;Steimer, WIntermediate metabolizer: increased side effects in psychoactive drug therapy. The key to cost-effectiveness of pretreatment CYP2D6 screening?Pharmacogenomics J200996395-403
Nguyen, DL;Staeker, J;Laika, B;Steimer, WTaqMan real-time PCR quantification strategy of CYP2D6 gene copy number for the LightCycler 2.0.Clin Chim Acta20094031-2207-11
Thaler, M;Buhl, A;Welter, H;Schreiegg, A;Kehrel, M;Alber, B;Metzger, J;Luppa, PBBiosensor analyses of serum autoantibodies: application to antiphospholipid syndrome and systemic lupus erythematosus.Anal Bioanal Chem200939351417-29
Popp, J;Leucht, S;Heres, S;Steimer, WDRD4 48 bp VNTR but not 5-HT 2C Cys23Ser receptor polymorphism is related to antipsychotic-induced weight gain.Pharmacogenomics J20099171-7